PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1119099
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1119099
Global Specialty Generics Market Size study, by Type (Injectables, Oral Drugs, Others), By Application (Oncology, Inflammatory Conditions, Hepatitis C, Multiple Sclerosis, Others) by End-use (, Retail, Hospital, Others) and Regional Forecasts 2022-2028
Global Specialty Generics Market is valued approximately USD 67.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2022-2028. When a specialty drug's patent expires, it's replaced with a generic version. These medications are used to treat chronic or complicated medical problems such as cancer, autoimmune disorders, epilepsy, and HIV. The growing acceptance of specialty generic drugs for the treatment of complicated chronic illnesses such as hepatitis C, as well as their increasing prevalence, is a significant market driver. According to the World Health Organization (WHO) report 2022, over 58 million individuals worldwide have chronic hepatitis C virus infection, with approximately 1.5 million persons infected yearly. Due to weakened immunity and high comorbid conditions, age is a key risk factor for the increased incidence of complicated chronic illnesses such as arthritis, cardiovascular disease, and cancer. According to the World Health Organization (WHO) the elderly population climbed from 1 billion in 2020 to 1.4 billion in 2021., By 2030, one in every six persons on the planet will be 60 or older. As a result, the industry's fast rising senior population is likely to generate profitable growth prospects. To increase their market share, major pharmaceutical corporations have engaged in mergers and acquisitions. BioCena bought a Pfizer-owned Australian factory for medication therapy manufacture in October 2021. In addition, BioCena finalized the acquisition of Pfizer Inc., which is owned by Hospira Adelaide, in 2020. It is a major provider of 200 specialized generic injectables in the United States. During the projected period, such strategic activities are expected to fuel market growth. However, brand recognition and loyalty, the high complexity of specialty generic goods, and limited profitability are some of the key entry obstacles for new participants in the business, all of which contribute to growing prescription costs. Teva Pharmaceutical Industries Ltd., for example, provided smart co-pay cards to Multiple Sclerosis (MS) sufferers in order for them to purchase COPAXONE for their treatment. Cardholders who qualify receive medications at no cost. Such campaigns draw customers' attention to their branded items, reducing the sales of specialist generic products.
The key regions considered for the Global Specialty Generics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the speciality generics market due to favourable regulatory laws governing the approval of new drugs, and contributed 36.5% of total revenue in 2021. The FDA in the United States has launched many attempts to improve the overall approval process. As a result, the United States Food and Drug Administration (FDA) proposed Generic Drug User Fee Amendments (GDUFA) under the Hatch-Waxman Act to accelerate the delivery of safe and effective low-cost generic medications to the public. As a result, prominent manufacturers are always working to commercialise specialty generic medications in the market. Amneal Pharmaceuticals Inc., for example, introduced LYVISPAH (baclofen) in June 2022, a specialty medication approved by the US FDA for the treatment of multiple sclerosis and other spinal cord illnesses.
Major market player included in this report are:
Teva Pharmaceuticals Industries Ltd.
Viatris Inc.
Novartis AG (Sandoz International GmbH)
Hikma Pharmaceuticals PLC
Mallinckrodt
Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)
Dr. Reddy's Laboratories Ltd.
Endo Pharmaceuticals Inc.
Apotex Corp.
Sun Pharmaceutical Industries Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Injectables
Oral Drugs
Others
By Application:
Oncology
Inflammatory Conditions
Hepatitis C
Multiple Sclerosis
Others
By End-use:
Retail
Hospital
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Specialty Generics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Specialty Generics Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Specialty Generics Market, by Type, 2020-2028 (USD Billion)
- 1.2.3. Specialty Generics Market, by Application, 2020-2028 (USD Billion)
- 1.2.4. Specialty Generics Market, by End-use, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Specialty Generics Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Specialty Generics Market Dynamics
- 3.1. Specialty Generics Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing adoption of specialty generic medicines for the treatment of complex chronic diseases.
- 3.1.1.2. Rising prevalence of complex chronic diseases such as arthritis, cardiovascular diseases, and cancer
- 3.1.2. Market Challenges
- 3.1.2.1. High complex nature of specialty generic products
- 3.1.3. Market Opportunities
- 3.1.3.1. Advancements in Formulation
- 3.1.1. Market Drivers
Chapter 4. Global Specialty Generics Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Specialty Generics Market, by Type
- 6.1. Market Snapshot
- 6.2. Global Specialty Generics Market by Type, Performance - Potential Analysis
- 6.3. Global Specialty Generics Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
- 6.4. Specialty Generics Market, Sub Segment Analysis
- 6.4.1. Injectables
- 6.4.2. Oral Drugs
- 6.4.3. Others
Chapter 7. Global Specialty Generics Market, by Application
- 7.1. Market Snapshot
- 7.2. Global Specialty Generics Market by Application, Performance - Potential Analysis
- 7.3. Global Specialty Generics Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
- 7.4. Specialty Generics Market, Sub Segment Analysis
- 7.4.1. Oncology
- 7.4.2. Inflammatory Conditions
- 7.4.3. Hepatitis C
- 7.4.4. Multiple Sclerosis
- 7.4.5. Others
Chapter 8. Global Specialty Generics Market, by End-use
- 8.1. Market Snapshot
- 8.2. Global Specialty Generics Market by End-use, Performance - Potential Analysis
- 8.3. Global Specialty Generics Market Estimates & Forecasts by End-use 2018-2028 (USD Billion)
- 8.4. Specialty Generics Market, Sub Segment Analysis
- 8.4.1. Hospitals
- 8.4.2. Retail Pharmacies
- 8.4.3. Others
Chapter 9. Global Specialty Generics Market, Regional Analysis
- 9.1. Specialty Generics Market, Regional Market Snapshot
- 9.2. North America Specialty Generics Market
- 9.2.1. U.S. Specialty Generics Market
- 9.2.1.1. Type breakdown estimates & forecasts, 2018-2028
- 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
- 9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
- 9.2.2. Canada Specialty Generics Market
- 9.2.1. U.S. Specialty Generics Market
- 9.3. Europe Specialty Generics Market Snapshot
- 9.3.1. U.K. Specialty Generics Market
- 9.3.2. Germany Specialty Generics Market
- 9.3.3. France Specialty Generics Market
- 9.3.4. Spain Specialty Generics Market
- 9.3.5. Italy Specialty Generics Market
- 9.3.6. Rest of Europe Specialty Generics Market
- 9.4. Asia-Pacific Specialty Generics Market Snapshot
- 9.4.1. China Specialty Generics Market
- 9.4.2. India Specialty Generics Market
- 9.4.3. Japan Specialty Generics Market
- 9.4.4. Australia Specialty Generics Market
- 9.4.5. South Korea Specialty Generics Market
- 9.4.6. Rest of Asia Pacific Specialty Generics Market
- 9.5. Latin America Specialty Generics Market Snapshot
- 9.5.1. Brazil Specialty Generics Market
- 9.5.2. Mexico Specialty Generics Market
- 9.6. Rest of The World Specialty Generics Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Teva Pharmaceuticals Industries Ltd
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. Viatris Inc.
- 10.2.3. Novartis AG (Sandoz International GmbH)
- 10.2.4. Hikma Pharmaceuticals PLC
- 10.2.5. Mallinckrodt
- 10.2.6. Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)
- 10.2.7. Dr. Reddy's Laboratories Ltd.
- 10.2.8. Endo Pharmaceuticals Inc.
- 10.2.9. Apotex Corp.
- 10.2.10. Sun Pharmaceutical Industries Ltd.
- 10.2.1. Teva Pharmaceuticals Industries Ltd
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption
LIST OF TABLES
- TABLE 1. Global Specialty Generics Market, report scope
- TABLE 2. Global Specialty Generics Market estimates & forecasts by Region 2018-2028 (USD Billion)
- TABLE 3. Global Specialty Generics Market estimates & forecasts by Type 2018-2028 (USD Billion)
- TABLE 4. Global Specialty Generics Market estimates & forecasts by Application 2018-2028 (USD Billion)
- TABLE 5. Global Specialty Generics Market estimates & forecasts by End-use 2018-2028 (USD Billion)
- TABLE 6. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 7. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 8. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 9. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 10. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 11. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 12. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 13. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 14. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 15. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 16. U.S. Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 17. U.S. Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 18. U.S. Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 19. Canada Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 20. Canada Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 21. Canada Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 22. UK Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 23. UK Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 24. UK Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 25. Germany Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 26. Germany Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 27. Germany Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 28. RoE Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 29. RoE Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 30. RoE Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 31. China Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 32. China Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 33. China Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 34. India Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 35. India Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 36. India Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 37. Japan Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 38. Japan Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 39. Japan Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 40. RoAPAC Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 41. RoAPAC Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 42. RoAPAC Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 43. Brazil Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 44. Brazil Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 45. Brazil Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 46. Mexico Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 47. Mexico Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 48. Mexico Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 49. RoLA Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 50. RoLA Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 51. RoLA Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 52. Row Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 53. Row Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 54. Row Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 55. List of secondary sources, used in the study of global Specialty Generics Market
- TABLE 56. List of primary sources, used in the study of global Specialty Generics Market
- TABLE 57. Years considered for the study
- TABLE 58. Exchange rates considered
LIST OF FIGURES
List of figures
- FIG 1. Global Specialty Generics Market, research methodology
- FIG 2. Global Specialty Generics Market, Market estimation techniques
- FIG 3. Global Market size estimates & forecast methods
- FIG 4. Global Specialty Generics Market, key trends 2021
- FIG 5. Global Specialty Generics Market, growth prospects 2022-2028
- FIG 6. Global Specialty Generics Market, porters 5 force model
- FIG 7. Global Specialty Generics Market, pest analysis
- FIG 8. Global Specialty Generics Market, value chain analysis
- FIG 9. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
- FIG 10. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
- FIG 11. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
- FIG 12. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
- FIG 13. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
- FIG 14. Global Specialty Generics Market, regional snapshot 2018 & 2028
- FIG 15. North America Specialty Generics Market 2018 & 2028 (USD Billion)
- FIG 16. Europe Specialty Generics Market 2018 & 2028 (USD Billion)
- FIG 17. Asia pacific Specialty Generics Market 2018 & 2028 (USD Billion)
- FIG 18. Latin America Specialty Generics Market 2018 & 2028 (USD Billion)
- FIG 19. Global Specialty Generics Market, company Market share analysis (2021)
